Methodology

All entries for: Metagenomi Therapeutics

March 5, 2026

Metagenomi Therapeutics

Neutral Outlook

Emeryville, CA
51-200 employees

The effects of the IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Cardiology, Hematology, Metabolic Diseases, Rare Diseases
Drug Type: Biologic
Source
Source
Scroll to Top